| Literature DB >> 17130579 |
Martin Ljungberg1, Riita Korpela, Jorma Ilonen, Johnny Ludvigsson, Outi Vaarala.
Abstract
The final aim of the PRODIA study is to determine whether the use of probiotics during the first 6 months of life decreases the appearance of type 1 diabetes mellitus (T1DM)-associated autoantibodies in children with genetic risk for T1DM. A pilot study including 200 subjects was planned to show whether the use of probiotics during the first 6 months of life is safe and feasible. The prevalence of autoantibodies among the study subjects at 6, 12, and 24 months of age was at levels close to the expected and the clinical follow-up did not either indicate problems in the feasibility of the study.Entities:
Mesh：
Substances：
Year: 2006 PMID： 17130579 DOI： 10.1196/annals.1375.055
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN： 0077-8923 Impact factor: 5.691